CDK4/6 inhibitors promote PARP1 degradation and synergize with PARP inhibitors in non-small cell lung cancer is a research paper published in Translational Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 5 P30 CA142543 09
US Office of Congressionally Directed Medical Research Programs
Grant: W81XWH-19-1-0645
NCI NIH HHS
Grant: P30 CA142543
National Institutes of Health
FWCI
2.34
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals